人工多能性幹細胞製造市場規模、成長と動向分析レポート 2025-2033年

人工多能性幹細胞製造市場 – プロセス別、ワークフロー別（リプログラミング、細胞培養）、製品別、用途別、最終用途別、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年

世界の人工多能性幹細胞製造市場規模は、2024年に16億2,000万米ドルに達すると推定され、2025年から2033年にかけて年平均成長率（CAGR）10.01%で成長し、2033年には37億8,000万米ドルに達すると予測されています。幹細胞ベースの治療法の可能性、がんの発生率の増加、幹細胞ベースの研究に対する資本投資、および胚性幹細胞（ESC）に対する人工多能性幹細胞（iPSC）のさまざまな利点が、市場の成長を大きく牽引しています。

人工多能性幹細胞（iPSC）由来細胞の創薬および毒性スクリーニングへの利用は、iPSC製造市場の主要な成長ドライバーとして台頭しています。製薬企業やバイオテクノロジー企業は、従来の細胞株や動物モデルよりもヒトの生物学的特性をよりよく模倣した、生理学的に適切なin vitroモデルを作成するために、iPSC由来の心筋細胞、肝細胞、神経細胞を採用するケースが増えています。これらのモデルは、ハイスループットスクリーニングを可能にし、初期段階の安全性および有効性評価を向上させるだけでなく、動物実験削減に向けた世界的な取り組みにも合致し、倫理的および規制上の期待を満たします。

Induced Pluripotent Stem Cells Production Market Summary

The global induced pluripotent stem cells production market size was estimated at USD 1.62 billion in 2024 and is projected to reach USD 3.78 billion by 2033, growing at a CAGR of 10.01% from 2025 to 2033. The potential of stem cell-based therapies, the growing incidence of cancer, capital investments for stem cell-based research, and multiple advantages of induced pluripotent stem cells (iPSCs) over embryonic stem cells (ESCs) are driving the market growth significantly.

Expanding Role of iPSC-Derived Cells in Drug Discovery and Toxicology Screening

The use of induced pluripotent stem cell (iPSC)-derived cells in drug discovery and toxicology screening is emerging as a major growth driver for the iPSC production market. Pharma and biotech companies are increasingly adopting iPSC-derived cardiomyocytes, hepatocytes, and neuronal cells to create physiologically relevant in vitro models that better mimic human biology than conventional cell lines or animal models. These models enable high-throughput screening, improve early-stage safety and efficacy assessments, and align with the global push to reduce animal testing, meeting ethical and regulatory expectations.

Induced Pluripotent Stem Cells Production Market Report Scope

Global Induced Pluripotent Stem Cells Production Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global induced pluripotent stem cells production market report based on process, workflow, product, application, end use, and region:

• Process Outlook (Revenue, USD Million, 2021 – 2033)
• Manual iPSC Production Process
• Automated iPSC Production Process
• Workflow Outlook (Revenue, USD Million, 2021 – 2033)
• Reprogramming
• Cell Culture
• Cell Characterization/Analysis
• Engineering
• Others
• Product Outlook (Revenue, USD Million, 2021 – 2033)
• Instruments/ Devices
• Automated Platforms
• Consumables & Kits

o Media

o Kits

o Others

• Services
• Application Outlook (Revenue, USD Million, 2021 – 2033)
• Drug Development & Discovery
• Regenerative Medicine
• Toxicology Studies
• Others
• End Use Outlook (Revenue, USD Million, 2021 – 2033)
• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies
• Hospitals & Clinics
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.2.1. Process

1.2.2. Workflow

1.2.3. Product

1.2.4. Application

1.2.5. End Use

1.3. Information analysis

1.4. Market formulation & data visualization

1.5. Data validation & publishing

1.6. Information Procurement

1.6.1. Primary Research

1.7. Information or Data Analysis

1.8. Market Formulation & Validation

1.9. Market Model

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Expanding Role of iPSC Derived Cells in Drug Discovery and Toxicology Screening

3.2.1.2. Growing Adoption of iPSC in Personalized and Precision Medicine

3.2.2. Market Restraint Analysis

3.2.2.1. Stringent process control and regulatory challenges

3.2.2.2. High cost of production

3.3. Industry Analysis Tools

3.3.1. Porter’s Five Forces Analysis

3.3.2. PESTEL Analysis

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

4.1. Technology Segment Dashboard

4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis

4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)

4.4. Manual iPSC Production Process

4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2021 – 2033 (USD Million)

4.5. Automated iPSC Production Process

4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

5.1. Workflow Segment Dashboard

5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis

5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)

5.4. Reprogramming

5.4.1. Global Reprogramming Market Estimates and Forecasts, 2021 – 2033 (USD Million)

5.5. Cell Culture

5.5.1. Global Cell Culture Market Estimates and Forecasts, 2021 – 2033 (USD Million)

5.6. Cell Characterization/Analysis

5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2021 – 2033 (USD Million)

5.7. Engineering

5.7.1. Global Engineering Market Estimates and Forecasts, 2021 – 2033 (USD Million)

5.8. Others

5.8.1. Global Others Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

6.1. Product Segment Dashboard

6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis

6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)

6.4. Instrument/Devices

6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.5. Automated Platforms

6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6. Consumables & Kits

6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6.2. Media

6.6.2.1. Global Media Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6.3. Kits

6.6.3.1. Global Kits Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.6.4. Others

6.6.4.1. Global Others Market Estimates and Forecasts, 2021 – 2033 (USD Million)

6.7. Services

6.7.1. Global Services Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

7.1. Sample Type Segment Dashboard

7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis

7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)

7.4. Drug Development and Discovery

7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.5. Regenerative Medicine

7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.6. Toxicology Studies

7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2021 – 2033 (USD Million)

7.7. Others

7.7.1. Global Others Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

8.1. End Use Segment Dashboard

8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis

8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)

8.4. Research & Academic Institutes

8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.5. Biotechnology & Pharmaceutical Companies

8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2021 – 2033 (USD Million)

8.6. Hospitals & Clinics

8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

9.1. Regional Dashboard

9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033

9.3. North America

9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.3.2. U.S.

9.3.2.1. Key Country Dynamics

9.3.2.2. Competitive Scenario

9.3.2.3. Regulatory Framework

9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.3.3. Canada

9.3.3.1. Key Country Dynamics

9.3.3.2. Competitive Scenario

9.3.3.3. Regulatory Framework

9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.3.4. Mexico

9.3.4.1. Key Country Dynamics

9.3.4.2. Competitive Scenario

9.3.4.3. Regulatory Framework

9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4. Europe

9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.2. UK

9.4.2.1. Key Country Dynamics

9.4.2.2. Competitive Scenario

9.4.2.3. Regulatory Framework

9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.3. Germany

9.4.3.1. Key Country Dynamics

9.4.3.2. Competitive Scenario

9.4.3.3. Regulatory Framework

9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.4. France

9.4.4.1. Key Country Dynamics

9.4.4.2. Competitive Scenario

9.4.4.3. Regulatory Framework

9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.5. Italy

9.4.5.1. Key Country Dynamics

9.4.5.2. Competitive Scenario

9.4.5.3. Regulatory Framework

9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.6. Spain

9.4.6.1. Key Country Dynamics

9.4.6.2. Competitive Scenario

9.4.6.3. Regulatory Framework

9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.7. Denmark

9.4.7.1. Key Country Dynamics

9.4.7.2. Competitive Scenario

9.4.7.3. Regulatory Framework

9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.8. Sweden

9.4.8.1. Key Country Dynamics

9.4.8.2. Competitive Scenario

9.4.8.3. Regulatory Framework

9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.4.9. Norway

9.4.9.1. Key Country Dynamics

9.4.9.2. Competitive Scenario

9.4.9.3. Regulatory Framework

9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5. Asia Pacific

9.5.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.2. Japan

9.5.2.1. Key Country Dynamics

9.5.2.2. Competitive Scenario

9.5.2.3. Regulatory Framework

9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.3. China

9.5.3.1. Key Country Dynamics

9.5.3.2. Competitive Scenario

9.5.3.3. Regulatory Framework

9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.4. India

9.5.4.1. Key Country Dynamics

9.5.4.2. Competitive Scenario

9.5.4.3. Regulatory Framework

9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.5. Australia

9.5.5.1. Key Country Dynamics

9.5.5.2. Competitive Scenario

9.5.5.3. Regulatory Framework

9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.6. Thailand

9.5.6.1. Key Country Dynamics

9.5.6.2. Competitive Scenario

9.5.6.3. Regulatory Framework

9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.5.7. South Korea

9.5.7.1. Key Country Dynamics

9.5.7.2. Competitive Scenario

9.5.7.3. Regulatory Framework

9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.6. Latin America

9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.6.2. Brazil

9.6.2.1. Key Country Dynamics

9.6.2.2. Competitive Scenario

9.6.2.3. Regulatory Framework

9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.6.3. Argentina

9.6.3.1. Key Country Dynamics

9.6.3.2. Competitive Scenario

9.6.3.3. Regulatory Framework

9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.7. MEA

9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.7.2. South Africa

9.7.2.1. Key Country Dynamics

9.7.2.2. Competitive Scenario

9.7.2.3. Regulatory Framework

9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.7.3. Saudi Arabia

9.7.3.1. Key Country Dynamics

9.7.3.2. Competitive Scenario

9.7.3.3. Regulatory Framework

9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.7.4. UAE

9.7.4.1. Key Country Dynamics

9.7.4.2. Competitive Scenario

9.7.4.3. Regulatory Framework

9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

9.7.5. Kuwait

9.7.5.1. Key Country Dynamics

9.7.5.2. Competitive Scenario

9.7.5.3. Regulatory Framework

9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021 – 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Categorization

10.2. Strategy Mapping

10.3. Company Market Position Analysis, 2024

10.4. Participant’s Overview

10.4.1. Lonza

10.4.1.1. Overview

10.4.1.2. Financial Performance

10.4.1.3. Product Benchmarking

10.4.1.4. Strategic Initiatives

10.4.2. Axol Bioscience Ltd.

10.4.2.1. Overview

10.4.2.2. Financial Performance

10.4.2.3. Product Benchmarking

10.4.2.4. Strategic Initiatives

10.4.3. Evotec

10.4.3.1. Overview

10.4.3.2. Financial Performance

10.4.3.3. Product Benchmarking

10.4.3.4. Strategic Initiatives

10.4.4. Hitachi, Ltd.

10.4.4.1. Overview

10.4.4.2. Financial Performance

10.4.4.3. Product Benchmarking

10.4.4.4. Strategic Initiatives

10.4.5. REPROCELL Inc.

10.4.5.1. Overview

10.4.5.2. Financial Performance

10.4.5.3. Product Benchmarking

10.4.5.4. Strategic Initiatives

10.4.6. Merck KGaA

10.4.6.1. Overview

10.4.6.2. Financial Performance

10.4.6.3. Product Benchmarking

10.4.6.4. Strategic Initiatives

10.4.7. Fate Therapeutics

10.4.7.1. Overview

10.4.7.2. Financial Performance

10.4.7.3. Product Benchmarking

10.4.7.4. Strategic Initiatives

10.4.8. Thermo Fisher Scientific, Inc.

10.4.8.1. Overview

10.4.8.2. Financial Performance

10.4.8.3. Product Benchmarking

10.4.8.4. Strategic Initiatives

10.4.9. StemCellsFactory III

10.4.9.1. Overview

10.4.9.2. Financial Performance

10.4.9.3. Product Benchmarking

10.4.9.4. Strategic Initiatives

10.4.10. Applied StemCells, Inc.

10.4.10.1. Overview

10.4.10.2. Financial Performance

10.4.10.3. Product Benchmarking

10.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources

Table 2 List of abbreviations

Table 3 Global induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 4 Global induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 5 Global induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 6 Global induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 7 Global induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 8 Global induced pluripotent stem cells production market, by region, 2021 – 2033 (USD Million)

Table 9 North America induced pluripotent stem cells production market, by country, 2021 – 2033 (USD Million)

Table 10 North America induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 11 North America induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 12 North America induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 13 North America induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 14 North America induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 15 U.S. induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 16 U.S. induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 18 U.S. induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 19 U.S. induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 20 Canada induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 21 Canada induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 22 Canada induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 23 Canada induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 24 Canada induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 25 Mexico induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 26 Mexico induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 28 Mexico induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 29 Mexico induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 30 Europe induced pluripotent stem cells production market, by country, 2021 – 2033 (USD Million)

Table 31 Europe induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 32 Europe induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 33 Europe induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 34 Europe induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 35 Europe induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 36 UK induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 37 UK induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 38 UK induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 39 UK induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 40 UK induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 41 Germany induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 42 Germany induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 43 Germany induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 44 Germany induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 45 Germany induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 46 France induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 47 France induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 48 France induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 49 France induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 50 France induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 51 Italy induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 52 Italy induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 53 Italy induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 54 Italy induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 55 Italy induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 56 Spain induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 57 Spain induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 58 Spain induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 59 Spain induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 60 Spain induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 61 Denmark induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 62 Denmark induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 64 Denmark induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 65 Denmark induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 66 Sweden induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 67 Sweden induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 69 Sweden induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 70 Sweden induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 71 Norway induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 72 Norway induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 73 Norway induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 74 Norway induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 75 Norway induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 76 Asia Pacific induced pluripotent stem cells production market, by country, 2021 – 2033 (USD Million)

Table 77 Asia Pacific induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 78 Asia Pacific induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 79 Asia Pacific induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 80 Asia Pacific induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 81 Asia Pacific induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 82 Japan induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 83 Japan induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 84 Japan induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 85 Japan induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 86 Japan induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 87 China induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 88 China induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 89 China induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 90 China induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 91 China induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 92 India induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 93 India induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 94 India induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 95 India induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 96 India induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 97 Australia induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 98 Australia induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 99 Australia induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 100 Australia induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 101 Australia induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 102 Thailand induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 103 Thailand induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 105 Thailand induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 106 Thailand induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 107 South Korea induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 108 South Korea induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 110 South Korea induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 111 South Korea induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 112 Latin America induced pluripotent stem cells production market, by country, 2021 – 2033 (USD Million)

Table 113 Latin America induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 114 Latin America induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 116 Latin America induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 117 Latin America induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 118 Brazil induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 119 Brazil induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 121 Brazil induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 122 Brazil induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 123 Argentina induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 124 Argentina induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 126 Argentina induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 127 Argentina induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2021 – 2033 (USD Million)

Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 134 South Africa induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 135 South Africa induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 137 South Africa induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 138 South Africa induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 144 UAE induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 145 UAE induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 146 UAE induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 147 UAE induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 148 UAE induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

Table 149 Kuwait induced pluripotent stem cells production market, by product, 2021 – 2033 (USD Million)

Table 150 Kuwait induced pluripotent stem cells production market, by process, 2021 – 2033 (USD Million)

Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2021 – 2033 (USD Million)

Table 152 Kuwait induced pluripotent stem cells production market, by application, 2021 – 2033 (USD Million)

Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 Induced pluripotent stem cells production market segmentation

Fig. 2 Market research process

Fig. 3 Data triangulation techniques

Fig. 4 Primary research pattern

Fig. 5 Market research approaches

Fig. 6 Market formulation & validation

Fig. 7 Market outlook

Fig. 8 Segment snapshot

Fig. 9 Competitive landscape snapshot

Fig. 10 Parent market outlook

Fig. 11 Induced pluripotent stem cells production market driver analysis

Fig. 12 Induced pluripotent stem cells production market restraint analysis

Fig. 13 Induced pluripotent stem cells production market: Porter’s analysis

Fig. 14 Induced pluripotent stem cells production market: PESTEL analysis

Fig. 15 Induced pluripotent stem cells production market: Product outlook and key takeaways

Fig. 16 Induced pluripotent stem cells production market: Product market share analysis, 2021 – 2033

Fig. 17 Global induced pluripotent stem cells production by instruments/devices market, 2021 – 2033 (USD Million)

Fig. 18 Global induced pluripotent stem cells production by automated platforms market, 2021 – 2033 (USD Million)

Fig. 19 Global induced pluripotent stem cells production by consumables & kits market, 2021 – 2033 (USD Million)

Fig. 20 Global induced pluripotent stem cells production by kits market, 2021 – 2033 (USD Million)

Fig. 21 Global induced pluripotent stem cells production by media market, 2021 – 2033 (USD Million)

Fig. 22 Global induced pluripotent stem cells production by others market, 2021 – 2033 (USD Million)

Fig. 23 Global induced pluripotent stem cells production by services market, 2021 – 2033 (USD Million)

Fig. 24 Induced pluripotent stem cells production market: Process outlook and key takeaways

Fig. 25 Induced pluripotent stem cells production market: Process market share analysis, 2021 – 2033

Fig. 26 Global induced pluripotent stem cells production by manual iPSC production process market, 2021 – 2033 (USD Million)

Fig. 27 Global induced pluripotent stem cells production by automated iPSC production process market, 2021 – 2033 (USD Million)

Fig. 28 Induced pluripotent stem cells production market: Workflow outlook and key takeaways

Fig. 29 Induced pluripotent stem cells production market: Workflow market share analysis, 2021 – 2033

Fig. 30 Global induced pluripotent stem cells production by reprogramming market, 2021 – 2033 (USD Million)

Fig. 31 Global induced pluripotent stem cells production by cell culture market, 2021 – 2033 (USD Million)

Fig. 32 Global induced pluripotent stem cells production by cell characterization/analysis market, 2021 – 2033 (USD Million)

Fig. 33 Global induced pluripotent stem cells production by engineering market, 2021 – 2033 (USD Million)

Fig. 34 Global induced pluripotent stem cells production by others market, 2021 – 2033 (USD Million)

Fig. 35 Induced pluripotent stem cells production market: Application outlook and key takeaways

Fig. 36 Induced pluripotent stem cells production market: Application market share analysis, 2021 – 2033

Fig. 37 Global induced pluripotent stem cells production by drug development & discovery market, 2021 – 2033 (USD Million)

Fig. 38 Global induced pluripotent stem cells production by regenerative medicine market, 2021 – 2033 (USD Million)

Fig. 39 Global induced pluripotent stem cells production by toxicology studies market, 2021 – 2033 (USD Million)

Fig. 40 Global induced pluripotent stem cells production by others market, 2021 – 2033 (USD Million)

Fig. 41 Induced pluripotent stem cells production market: End use outlook and key takeaways

Fig. 42 Induced pluripotent stem cells production market: End use market share analysis, 2021 – 2033

Fig. 43 Global induced pluripotent stem cells production by research & academic institutes market, 2021 – 2033 (USD Million)

Fig. 44 Global induced pluripotent stem cells production by biotechnology & pharmaceutical companies market, 2021 – 2033 (USD Million)

Fig. 45 Global induced pluripotent stem cells production by hospitals & clinics market, 2021 – 2033 (USD Million)

Fig. 46 Regional marketplace: Key takeaways

Fig. 47 North America induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 48 U.S. induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 49 Canada induced pluripotent stem cells production market, 2021 – 2033 (USD Million)

Fig. 50 Mexico induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 51 Europe induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 52 UK induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 53 Germany induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 54 France induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 55 Italy induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 56 Spain induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 57 Denmark induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 58 Sweden induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 59 Norway induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 60 Asia-Pacific induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 61 Japan induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 62 China induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 63 India induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 64 Australia induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 65 Thailand induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 66 South Korea induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 67 Latin America induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 68 Brazil induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 69 Argentina induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 70 MEA induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 71 South Africa induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 72 Saudi Arabia induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 73 UAE induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 74 Kuwait induced pluripotent stem cells production market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 75 Key company categorization

Fig. 76 Company market positioning

Fig. 77 Market participant categorization

Fig. 78 Strategy framework

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• イーサネット測定機器市場規模、成長と動向分析レポート 2025-2033年
• AIビデオ分析市場規模、成長と動向分析レポート 2025-2033年
• イベントマネジメント市場規模、成長と動向分析レポート 2025-2033年
• IPTVソフトウェア市場規模、成長と動向分析レポート 2025-2033年
• スマートホームセキュリティカメラ市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧